Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

NRASG12V oncogene facilitates self-renewal in a murine model of acute myelogenous leukemia.

  • Read more about NRASG12V oncogene facilitates self-renewal in a murine model of acute myelogenous leukemia.

Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia.

  • Read more about Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia.

Hematopoietic stem cell dysfunction underlies the progressive lymphocytopenia in XLF/Cernunnos deficiency.

  • Read more about Hematopoietic stem cell dysfunction underlies the progressive lymphocytopenia in XLF/Cernunnos deficiency.

A(nother) RAF mutation in LCH.

  • Read more about A(nother) RAF mutation in LCH.

Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation.

  • Read more about Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation.

Mutations in GATA2 are rare in juvenile myelomonocytic leukemia.

  • Read more about Mutations in GATA2 are rare in juvenile myelomonocytic leukemia.

Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations.

  • Read more about Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations.

GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.

  • Read more about GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.

Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection.

  • Read more about Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection.

SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.

  • Read more about SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.

Pagination

  • Previous page ‹‹
  • Page 13
  • Next page ››
Subscribe to Blood

Pediatrics Home

MAKE A GIFT

© 2026 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                   Accessibility  Privacy Policy  Terms of Use  A-Z Website List